4
Changes in Ownership
Iambic Therapeutics, Inc. Filed Acc 0002151678-26-000005
Options or other derivatives
- Director acquired 20,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rachlin Evan Lockwood Director | 2026-10-14 | Grant or award · Stock Option (right to buy) | +20,300 | 20,300 | D | ||
Loading xslF345X06/form4-10162026_081024.xml…